{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:07:13Z","timestamp":1777086433386,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.nmd.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T21:15:46Z","timestamp":1680124546000},"page":"511-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["254th ENMC international workshop. Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28 \u2013 30 January 2022"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-4827","authenticated-orcid":false,"given":"Maggie C.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Attarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenija","family":"Gorni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Goemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Gusset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Hodgkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Hagenacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kostera-Pruszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Muni-Lofra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Ouillade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaline","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Prigent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria A","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivka","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Smeriglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Tichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F","family":"Vazquez-Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.03.011_bib0001","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JND-200534","article-title":"Measuring outcomes in adults with spinal muscular atrophy - challenges and future directions - meeting report","volume":"7","author":"Sansone","year":"2020","journal-title":"J Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2","volume":"78","author":"Cartegni","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2023.03.011_bib0003","first-page":"3149","article-title":"hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing","volume":"16","author":"Kashima","year":"2007","journal-title":"Am Mol Genet"},{"key":"10.1016\/j.nmd.2023.03.011_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2023.03.011_bib0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/ene.13534","article-title":"Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4","volume":"25","author":"Wadman","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"CHERISH study group. Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2023.03.011_bib0009","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2102047","article-title":"FIREFISH working group. Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls","volume":"385","author":"Darras","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2023.03.011_bib0010","article-title":"Risdiplam in types 2 and 3 spinal muscular atrophy: a randomised, placebo-controlled, dose-finding trial followed by 24\u2009months of treatment","author":"Mercuri","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0011","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s13311-022-01200-3","article-title":"Nusinersen in adults with 5q spinal muscular atrophy: a systematic review and meta-analysis","volume":"19","author":"Gavriilaki","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nmd.2023.03.011_bib0012","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3389\/fneur.2019.01098","article-title":"Patient-reported prevalence of non-motor symptoms is low in adult patients suffering from 5q spinal muscular atrophy","volume":"10","author":"G\u00fcnther","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0013","doi-asserted-by":"crossref","first-page":"e1988","DOI":"10.1212\/WNL.0000000000010540","article-title":"Muscle strength and motor function in adolescents and adults with spinal muscular atrophy","volume":"95","author":"Wijngaarde","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.03.011_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13023-019-0998-4","article-title":"SMArtCARE - a platform to collect real-life outcome data of patients with spinal muscular atrophy","volume":"14","author":"Pechmann","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2023.03.011_bib0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nmd.2021.03.012","article-title":"Age related treatment effect in type II spinal muscular atrophy pediatric patients treated with Nusinersen","volume":"31","author":"Coratti","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JND-190416","article-title":"Safety and treatment effects of nusinersen in longstanding adult 5q-SMA Type 3 - a prospective observational study","volume":"6","author":"Walter","year":"2019","journal-title":"J Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","article-title":"Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study","volume":"19","author":"Hagenacker","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0018","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/jnnp-2020-323822","article-title":"Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3","volume":"91","author":"Maggi","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.03.011_bib0019","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1111\/ene.15542","article-title":"Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy","volume":"29","author":"V\u00e1zquez-Costa","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0020","article-title":"Validation of neuromyotype: a smart keyboard for the evaluation of spinal muscular atrophy patients","author":"Lizandra Cort\u00e9s","year":"2022","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.nmd.2023.03.011_bib0021","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s00415-020-10332-5","article-title":"Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study","volume":"268","author":"Querin","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40120-022-00411-2","article-title":"Validation of a set of instruments to assess patient- and caregiver-oriented measurements in spinal muscular atrophy: results of the SMA-TOOL study","volume":"12","author":"V\u00e1zquez-Costa","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nmd.2023.03.011_bib0023","first-page":"88","article-title":"Natural history of lung function in spinal muscular atrophy","volume":"15","author":"Wijngaarde","year":"2020","journal-title":"OJRD"},{"key":"10.1016\/j.nmd.2023.03.011_bib0024","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.26285","article-title":"Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development","volume":"91","author":"Paganoni","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2021.1272","article-title":"Five-year extension results of the phase 1 START trial of onasemnogene abeparvovec in spinal muscular atrophy","volume":"78","author":"Mendell","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0026","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s40264-021-01107-6","article-title":"Clinical trial and postmarketing safety of onasemnogene abeparvovec therapy","volume":"44","author":"Day","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.nmd.2023.03.011_bib0027","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2019.01166","article-title":"Clinical implication of dosimetry of computed tomography- and fluoroscopy-guided intrathecal therapy with Nusinersen in adult patients with spinal muscular atrophy","volume":"10","author":"Kizina","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00234-021-02643-9","article-title":"Ultra-low radiation dose protocol for CT-guided intrathecal Nusinersen injections for patients with spinal muscular atrophy and severe scoliosis","volume":"63","author":"Rosiak","year":"2021","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nmd.2023.03.011_bib0029","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/ene.14245","article-title":"Computed-tomography-guided transforaminal intrathecal Nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations","volume":"27","author":"Spiliopoulus","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ene.14586","article-title":"Ultrasound-guided lumbar puncture for Nusinersen administration in spinal muscular atrophy patients","volume":"28","author":"Veiga-Canuto","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0031","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awy330","article-title":"Key role of SMN\/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-seq and motif analysis of human motor neurons","volume":"142","author":"Rizzo","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2023.03.011_bib0032","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-020-02133-x","article-title":"Synaptotagmin 13 is neuroprotective across motor neuron diseases","volume":"139","author":"Nizzardo","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0033","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14953","article-title":"Cerebrospinal fluid proteomic profiling in Nusinersen-treated patients with spinal muscular atrophy","volume":"153","author":"Kessler","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.nmd.2023.03.011_bib0034","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0035","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.3390\/ijms20215397","article-title":"Neurofilament heavy chain and tau protein are not elevated in cerebrospinal fluid of adult patients with spinal muscular atrophy during loading with Nusinersen","volume":"20","author":"Totzeck","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2023.03.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/11772719211035643","article-title":"Update on biomarkers in spinal muscular atrophy","volume":"16","author":"Pino","year":"2021","journal-title":"Biomark Insights"},{"key":"10.1016\/j.nmd.2023.03.011_bib0037","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nrl.2021.07.008","article-title":"Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus)","volume":"37","author":"Pitarch Castellano","year":"2022","journal-title":"Neurologia"},{"key":"10.1016\/j.nmd.2023.03.011_bib0038","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1111\/ene.15522","article-title":"Treatment of spinal muscular atrophy in European countries: a call to action","volume":"29","author":"V\u00e1zquez-Costa","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0039","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3233\/JND-200611","article-title":"Improving care and empowering adults living with SMA: a call to action in the new treatment era","volume":"8","author":"Walter","year":"2021","journal-title":"J Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","article-title":"Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials","volume":"26","author":"Mercuri","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.011_bib0041","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.03.011_bib0042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"Natural history of type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2023.03.011_bib0043","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000000796","article-title":"Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia","volume":"83","author":"Wadmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.03.011_bib0044","first-page":"703","article-title":"Spinal muscular atrophy - expert recommendations for the use of Nusinersen in adult patients]","volume":"87","author":"Hagenacker","year":"2019","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.nmd.2023.03.011_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.18071\/isz.74.0079","article-title":"Consensus statement of the hungarian clinical neurogenic society about the therapy of adult SMA patients","volume":"74","author":"Bocz\u00e1n","year":"2021","journal-title":"Ideggyogy Szle"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:36Z","timestamp":1760775216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0960896623000950"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.03.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"254th ENMC international workshop. Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28 \u2013 30 January 2022","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}